Mean Platelet Volume as a Potential Predictor of Cholesteatoma in Children

Mehmet Akif Eryilmaz1, Serhan Derin

  • 1*Otorhinolaryngology Department, Meram Medical Faculty, Necmettin Erbakan Univerisity, Konya †Otorhinolaryngology Department, Mugla Sitki Kocman University, School of Medicine, Mugla, Turkey.

Insights

Mean platelet volume (MPV) may predict childhood cholesteatoma. Lower MPV levels in children with cholesteatoma suggest its utility as a reliable, inexpensive diagnostic marker for this chronic inflammatory condition.

Area of Science:

  • Otolaryngology
  • Pediatric Medicine
  • Inflammatory Disorders

Background:

  • Cholesteatoma is a destructive inflammatory condition of the middle ear, potentially causing hearing loss and complications.
  • Mean platelet volume (MPV) is recognized as a prothrombotic and proinflammatory marker.

Purpose of the Study:

  • To evaluate the predictive value of MPV and other hematological parameters for diagnosing cholesteatoma in pediatric chronic otitis media.
  • To compare these markers between cholesteatomatous, noncholesteatomatous, and healthy pediatric groups.

Main Methods:

  • Retrospective analysis of 24 patients with cholesteatomatous chronic otitis media, 9 with noncholesteatomatous chronic otitis media, and 36 healthy controls.
  • Comparison of white blood cell count, MPV, erythrocyte distribution width, neutrophil-to-lymphocyte ratio, and platelet lymphocyte ratio among the groups.

Main Results:

  • Mean platelet volume (MPV) was significantly lower in the cholesteatoma group (8.17 fL) versus controls (10.42 fL) (P < 0.001).
  • An MPV cutoff of 9.5 fL demonstrated high sensitivity (86%) and specificity (84%) for predicting cholesteatoma.
  • Other studied parameters showed no significant differences between cholesteatomatous and noncholesteatomatous groups.

Conclusions:

  • Mean platelet volume (MPV) shows potential as a rapid, reliable, and cost-effective marker for identifying cholesteatoma in children.
  • MPV's predictive capability offers a valuable tool for the early diagnosis of cholesteatoma in pediatric patients.
Abstract